Literature DB >> 6520229

Oligo-2',5'-adenylate synthetase activity in peripheral blood mononuclear leukocytes in various diseases.

N Fujii, S Kotake, S Hirose, S Ohno, I Yasuda, A Sagawa, K Ishikawa, T Minagawa.   

Abstract

Interferon induces oligo-2',5'-adenylate synthetase in cells. In various diseases, interferon was detectable in the circulation or was produced spontaneously from peripheral blood mononuclear leukocytes. The oligo-2',5'-adenylate synthetase activity in peripheral blood mononuclear leukocytes was examined in various diseases, including systemic lupus erythematosus, sarcoidosis, Vogt-Koyanagi-Harada disease, and Behcet's disease. The activity of this enzyme was significantly increased in systemic lupus erythematosus (P less than 0.01), sarcoidosis (P less than 0.01), and Vogt-Koyanagi-Harada disease (P less than 0.01) compared with that in controls, but the increase of activity was not significant in Behcet's disease (P greater than 0.05).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520229      PMCID: PMC271556          DOI: 10.1128/jcm.20.6.1216-1218.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase.

Authors:  A Zilberstein; A Kimchi; A Schmidt; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis.

Authors:  J J Hooks; G W Jordan; T Cupps; H M Moutsopoulos; A S Fauci; A L Notkins
Journal:  Arthritis Rheum       Date:  1982-04

3.  General considerations of the interferon system.

Authors:  S Baron; F Dianzani
Journal:  Tex Rep Biol Med       Date:  1977

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases.

Authors:  A Schattner; D Wallach; G Merlin; T Hahn; S Levin; M Revel
Journal:  Lancet       Date:  1981-09-05       Impact factor: 79.321

6.  Detection of gamma interferon in the sera of patients with Behçet's disease.

Authors:  S Ohno; F Kato; H Matsuda; N Fujii; T Minagawa
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Serum interferon levels in patients with systemic lupus erythematosus.

Authors:  S R Ytterberg; T J Schnitzer
Journal:  Arthritis Rheum       Date:  1982-04

8.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

Authors:  O T Preble; R J Black; R M Friedman; J H Klippel; J Vilcek
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

9.  Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.

Authors:  A Schattner; G Merlin; D Wallach; H Rosenberg; T Bino; T Hahn; S Levin; M Revel
Journal:  J Interferon Res       Date:  1981

10.  Spontaneous production of gamma-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease.

Authors:  N Fujii; T Minagawa; A Nakane; F Kato; S Ohno
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

  10 in total
  3 in total

1.  Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.

Authors:  N Fujii; K Oguma; M Fujii; R Fukatsu; N Takahata; M Kitabatake
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

2.  Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

Authors:  E C Short; R W Fulton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

3.  Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.

Authors:  H Sugino; I Mitani; M Koike; T Kodama; J Sokawa; H Sawai; K Ishibashi; M Itoh; S Watanabe; Y Sokawa
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.